Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow cell injection for no-option ischemic heart failure
NL-OMON23517Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised trial in Ischemic congestive heart failure (ICM-HF) and heart failure (HF) comparing Autologous bone marrow-derived mononuclear cells with Placebo (2 arms). Primary endpoint: Change in left ventricular ejection fraction. Started Apr 2010; status: recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Ischemic congestive heart failure (ICM-HF)heart failure (HF)
Beyond the preview
Go deeper on NL-OMON23517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23517.